The levels of plasma TNF-α (t=4.580, p<0.001) and IL-6 (z=-2.996, p<0.001) in MDD patients baseline and after treatment were higher than those in healthy controls, with no significant difference in biomarkers between baseline and after treatment (Table 3). Here, TNF is linked to major depressive disorder.